ERBB2 and breast cancer: For instance, a trastuzumab-conjugated liposomal formulation was engineered to co-encapsulate paclitaxel and anti-ABCB1 siRNA, to enhance cytotoxicity against HER2-positive breast cancer cells by silencing ABCB1, the gene encoding P-gp [223].